James R Whittle 30th Lorne Cancer Conference 2018

James R Whittle

Jim Whittle is Neuro Oncologist at the Peter MacCallum Cancer Centre (PeterMac) and joint-head of the Brain Cancer Research Laboratory at WEHI. Jim’s research expertise and reputation are built on a deep understanding of basic biology, the development of patient-derived models for drug discovery, and clinical translation. His clinical research focuses on implementing novel Phase 0 (Perioperative) clinical trials as part of a paradigm shift in drug development. An emerging leader in the field of Neuro Oncology, Jim has an established institutional and national profile, serving on the management committee and chairing the Outreach and Education Committee for the Cooperative Group for Neuro Oncology (COGNO), as well as participating in various committees within the Society of Neuro Oncology (SNO). In 2023, Jim was appointed Co-Director of Research Strategy at the Brain Cancer Centre (Melbourne) and sits on the research advisory committee for the Mark Hughes Foundation Centre for Brain Cancer Research.